Strides Pharma Science Limited has informed the Exchange about General Updates
STAR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Strides Pharma Science has informed the exchanges that it has sent a communication to its shareholders regarding the deduction of tax at source (TDS) on the final dividend declared for FY 2024-25. This follows the company's earlier intimation on July 9, 2025, about the record date and Annual General Meeting for FY 2024-25. The TDS communication was emailed to shareholders whose email addresses are registered with the company or depository participants. A newspaper advertisement was also published on July 10, 2025, in Business Standard (English, all editions) and Navshakti (Marathi), in line with regulatory requirements.
This is a routine regulatory compliance update related to the final dividend process and does not change the dividend amount or any shareholder entitlements. Investors should expect TDS to be deducted as applicable when the final dividend is paid.